Fry D - Search Results

1

Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Kandimalla R, Manczak M, Fry D, Suneetha Y, Sesaki H, Reddy PH. Kandimalla R, et al. Among authors: fry d. Hum Mol Genet. 2016 Nov 15;25(22):4881-4897. doi: 10.1093/hmg/ddw312. Hum Mol Genet. 2016. PMID: 28173111 Free PMC article.

2

Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Manczak M, Kandimalla R, Fry D, Sesaki H, Reddy PH. Manczak M, et al. Among authors: fry d. Hum Mol Genet. 2016 Dec 1;25(23):5148-5166. doi: 10.1093/hmg/ddw330. Hum Mol Genet. 2016. PMID: 27677309 Free PMC article.

3

Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer's Disease.

Reddy PH, Blackmon J, Molinar-Lopez V, Ament C, Manczak M, Kandimalla R, Yin X, Pandey A, Kuruva CS, Wang R, Fry D, Osborn C, Stonum K, Quesada K, Gonzales R, Boles A. Reddy PH, et al. Among authors: fry d. J Alzheimers Dis. 2015;48(2):547-55. doi: 10.3233/JAD-150490. J Alzheimers Dis. 2015. PMID: 26402018 Free PMC article.

4

Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2.

Owen JD, Ruest PJ, Fry DW, Hanks SK. Owen JD, et al. Among authors: fry dw. Mol Cell Biol. 1999 Jul;19(7):4806-18. doi: 10.1128/MCB.19.7.4806. Mol Cell Biol. 1999. PMID: 10373530 Free PMC article.

5

Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells.

Withers BE, Hanks SK, Fry DW. Withers BE, et al. Among authors: fry dw. Cancer Biochem Biophys. 1996 Apr;15(3):127-39. Cancer Biochem Biophys. 1996. PMID: 8937737

6

Expression, purification and characterization of focal adhesion kinase using a baculovirus system.

Withers BE, Keller PR, Fry DW. Withers BE, et al. Among authors: fry dw. Protein Expr Purif. 1996 Feb;7(1):12-8. doi: 10.1006/prep.1996.0002. Protein Expr Purif. 1996. PMID: 9172776

7

PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.

Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J. Bos M, et al. Among authors: fry dw. Clin Cancer Res. 1997 Nov;3(11):2099-106. Clin Cancer Res. 1997. PMID: 9815602

8

Inhibitors of tyrosine kinase.

Klohs WD, Fry DW, Kraker AJ. Klohs WD, et al. Among authors: fry dw. Curr Opin Oncol. 1997 Nov;9(6):562-8. doi: 10.1097/00001622-199711000-00012. Curr Opin Oncol. 1997. PMID: 9370078 Review.

9

Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor.

Gonzales AJ, Hook KE, Althaus IW, Ellis PA, Trachet E, Delaney AM, Harvey PJ, Ellis TA, Amato DM, Nelson JM, Fry DW, Zhu T, Loi CM, Fakhoury SA, Schlosser KM, Sexton KE, Winters RT, Reed JE, Bridges AJ, Lettiere DJ, Baker DA, Yang J, Lee HT, Tecle H, Vincent PW. Gonzales AJ, et al. Mol Cancer Ther. 2008 Jul;7(7):1880-9. doi: 10.1158/1535-7163.MCT-07-2232. Epub 2008 Jul 7. Mol Cancer Ther. 2008. PMID: 18606718

10

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase.

Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ. Fry DW, et al. Science. 1994 Aug 19;265(5175):1093-5. doi: 10.1126/science.8066447. Science. 1994. PMID: 8066447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

877 results

Search Page